Clinical Trials Logo

Normal Weight clinical trials

View clinical trials related to Normal Weight.

Filter by:
  • None
  • Page 1

NCT ID: NCT06185634 Recruiting - Normal Weight Clinical Trials

Impact of the Timing of Pasta Consumption on Health

Start date: November 13, 2023
Phase: N/A
Study type: Interventional

To date, the optimal timing for pasta consumption remains uncertain. Based on recent evidence in the field of chrono-nutrition, it is speculated that eating pasta at dinner may have a negative impact on cardio-metabolic health. Carbohydrate intake during a period of minimal glucose tolerance could potentially alter the glycaemic profile and increase the risk of overweight and obesity. Conversely, other studies indicate that consuming carbohydrates at dinner may enhance sleep efficiency and quality. Thus, the aim of this study is, for the first time, to evaluate whether there are discernible differences between consuming pasta at lunch or dinner for the human health.

NCT ID: NCT04686552 Completed - Clinical trials for Overweight and Obesity

Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses

CINNI
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The objective of the proposed study is to investigate the effect of cinnamon on the postprandial glycemic response to a high glycemic index meal in normal and overweight/obese prediabetic subjects

NCT ID: NCT04307628 Withdrawn - Healthy Clinical Trials

Response of Gut Microbiota and Cardiometabolic Biomarkers to Consumption of Walnuts

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The researchers will investigate blood and fecal responses in qualified study participants after eating walnuts for 4 weeks compared to not eating walnuts for 4 weeks. The two dietary interventions will be separated by a 4 week washout period. The order of diets will be random; study participants will complete both interventions. Dietary modifications will be part of the study protocol.

NCT ID: NCT04149288 Active, not recruiting - Healthy Clinical Trials

Olive Oil Polyphenols and Cardiovascular Health Biomarkers

Start date: October 6, 2021
Phase: N/A
Study type: Interventional

The purpose of this research is to investigate whether consuming two different kinds of olive oil will change risk factors related to cardiovascular disease, including levels of good and bad cholesterol, levels of inflammation, and levels of gene expression.

NCT ID: NCT04037020 Completed - Normal Weight Clinical Trials

The Chocolate Study 2.0

Start date: July 25, 2019
Phase:
Study type: Observational

The purpose of this study is to test how the brain responds when enjoyable foods such as chocolate are consumed. The investigators know that eating certain types of foods can make an individual want to keep eating even when he or she is full. The chemical in the brain that causes this is called dopamine. The investigators can measure this response by looking at changes to how an individual's eye responds to light.

NCT ID: NCT03223935 Completed - Overweight Clinical Trials

Roasted Pulse Snacks, Post-prandial Food Intake, Appetite, and Glycemia

Start date: August 11, 2017
Phase: N/A
Study type: Interventional

An investigation on the effects of roasted pulse snacks on post-prandial glycemic and satiety response in healthy young adults.

NCT ID: NCT01312051 Completed - Healthy Clinical Trials

Childhood Metabolic Markers of Adult Morbidity in Blacks

Start date: July 2004
Phase: N/A
Study type: Observational

Blacks are at increased risk for obesity, type 2 diabetes mellitus and cardiovascular disease. A common pathogenetic link among these entities is insulin resistance/hyperinsulinemia. The specific aims of this project are: 1) to compare skeletal muscle lipid content (SMLC) in black vs white children by computed tomography (CT) scan of the mid-thigh, and assess the relationship to in vivo insulin sensitivity; 2) to test the hypothesis that free fatty acid (FFA) - induced insulin resistance is associated with larger increases in intramyocellular lipid (IMCL) in black vs white adolescents; 3) to examine if β-cell insulin secretion in prepubertal black children is more sensitive to the stimulatory effect of FFA than in whites; and 4) to test if the β-cell in black obese adolescents is more susceptible to the lipotoxic effect of FFA compared with whites. The methods to be used are: the well- established CT method as well as Magnetic Resonance Spectroscopy (1H-MRS) to assess SMLC and IMCL; intralipid infusion to elevate circulating FFA levels; the hyperinsulinemic-euglycemic clamp with stable isotopes and indirect calorimetry to measure insulin sensitivity and substrate turnover; the hyperglycemic clamp to assess insulin secretion; DEXA and whole body MRI for body composition assessments.